This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2026 - Rare Disease Summit
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA

Sonit Handa
Former Senior Director, Global Expansion Program, Rare Disease at Horizon Therapeutics; Member Governing Board, The Jossleyn
Speaker

Profile

Sonit Handa, MD, MS, MBA, is a physician executive and consultant with over 20 years of experience leading rare disease commercialization and global product launches. He has led U.S. and ex-U.S. launches at Horizon Therapeutics and held senior roles across commercial, medical affairs, and operations at Astellas, Amgen, and Deloitte. As Founder of Biovance Consulting, Sonit created the PRECISION LAUNCH™ framework, working with biotech and pharma teams to de-risk launches, strengthen execution, and translate strategy into operational reality. He also serves on the Board of Directors of Josselyn, a nonprofit expanding access to mental health care.

Agenda Sessions

  • Bridging Borders – Aligning US and Global Rare Disease Launch Strategies

    3:15pm